Diabetes 54:2155-2163, 2005
© 2005 by the American Diabetes Association, Inc.
Impaired Arachidonic Acid–Mediated Activation of Large-Conductance Ca2+-Activated K+ Channels in Coronary Arterial Smooth Muscle Cells in Zucker Diabetic Fatty Rats
Tong Lu1,
Xiao-Li Wang1,
Tongrong He2,
Wei Zhou1,
Terry L. Kaduce3,
Zvonimir S. Katusic2,
Arthur A. Spector3, and
Hon-Chi Lee1
1 Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota
2 Department of Anesthesiology, Mayo Clinic, Rochester, Minnesota
3 Department of Biochemistry, University of Iowa, Iowa City, Iowa
We studied the arachidonic acid (AA)-mediated modulation of large-conductance Ca2+-activated K+ (BK) channels in coronary arterial smooth myocytes from lean control and Zucker Diabetic Fatty (ZDF) rats. A total of 1 µmol/l AA enhanced BK current by 274% in lean and by 98% in ZDF rats. After incubation with 10 µmol/l indomethacin, 1 µmol/l AA increased BK currents by 80% in lean and by 70% in ZDF rats. Vasoreactivity studies showed that the dilation of small coronary arteries produced by 1 µmol/l AA was reduced by 44% in ZDF rats. [3H]6-keto-prostagladin F1 ([3H]6-keto-PGF1 ,), the stable metabolite of prostacyclin (PGI2), was the major [3H]AA metabolite produced by coronary arteries of lean vessels, but ZDF vessels produced only 15% as much [3H]6-keto-PGF1 . BK channel activation and vasorelaxation by iloprost were similar in lean and ZDF rats. Immunoblots showed a 73% reduction in PGI2 synthase (PGIS) expression in ZDF vessels compared with lean vessels, and there was no change in cyclooxygenase (COX) and BK channel expressions. Real-time PCR studies showed that mRNA levels of PGIS, COX-1, and COX-2 were similar between lean and ZDF vessels. We conclude that PGI2 is the major AA metabolite in lean coronaries, and AA-mediated BK channel activation is impaired in ZDF coronaries due to reduced PGIS activity.
Address correspondence and reprint requests to Tong Lu, MD, PhD, Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic, 200 First St., SW, Rochester, MN 55905. E-mail: lu.tong{at}mayo.edu
Abbreviations:
6-keto-PGF1 , 6-keto-prostagladin F1 ; 12-HETE, 12-hydroxyeicosatetraenoic acid; AA, arachidonic acid; BK, large-conductance Ca2+-activated K+; COX, cyclooxygenase; CYP, cytochrome P450; DMEM, Dulbeccos modified Eagles medium; IBTX, iberiotoxin; IP, PGI2 receptor; LOX, lipoxygenase; PGI2, prostacyclin; PGIS, PGI2 synthase

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
W. Zhou, X.-L. Wang, K. G. Lamping, and H.-C. Lee
Inhibition of Protein Kinase Cbeta Protects against Diabetes-Induced Impairment in Arachidonic Acid Dilation of Small Coronary Arteries
J. Pharmacol. Exp. Ther.,
October 1, 2006;
319(1):
199 - 207.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Lu, T. He, Z. S. Katusic, and H.-C. Lee
Molecular Mechanisms Mediating Inhibition of Human Large Conductance Ca2+-Activated K+ Channels by High Glucose
Circ. Res.,
September 15, 2006;
99(6):
607 - 616.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Szerafin, N. Erdei, T. Fulop, E. T. Pasztor, I. Edes, A. Koller, and Z. Bagi
Increased Cyclooxygenase-2 Expression and Prostaglandin-Mediated Dilation in Coronary Arterioles of Patients With Diabetes Mellitus
Circ. Res.,
September 1, 2006;
99(5):
e12 - 317.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Diabetes Association.
|
|
| |
|